| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |